Ann-Kathrin Glosch

Circulating Cell-Free SEPT9 DNA Methylation in Blood Is a Biomarker for Minimal Residual Disease Detection in Head and Neck Squamous Cell Carcinoma Patients.

F. Bootz, D. Dietrich, P. Brossart, 2023, Clinical chemistry.